In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Rate and indications of reoperation after deep brain stimulation surgery

    Final Number:
    1547

    Authors:
    Angela Elizabeth Downes MD; Julio LB Pereira MD; Eric Benhke BS; Antonio DeSalles MD PhD; Nader Pouratian MD, PhD

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2013 Annual Meeting

    Introduction: Deep brain stimulation surgery is becoming increasingly popular amongst patients and surgeons as a treatment option for conditions such as Parkinson’s disease (PD), dystonia, tremor, and chronic pain. When making the decision to proceed with surgery, patients must be aware of the risk of needing future surgeries. We retrospectively analyzed the institutional case series to define the rate and indications of reoperation on DBS electrode(s).

    Methods: Patients who presented to UCLA for revision of their DBS systems from 1998 to 2013 were assessed by a clinical retrospective chart review. Patients who underwent revision surgery, defined as removal and replacement of one or both of their intracranial DBS electrodes were included, and those with generator or extension lead replacements were excluded. Revisions were assessed for indication, which included infection, suboptimal clinical outcome, or lead fracture.

    Results: A total of 651 DBS surgeries were performed over 15 years. 45 surgeries (6.9%) were revisions of intracranial leads. Patient diagnoses included PD 44%, tremor 34%, dystonia 19%, and chronic pain 3%. Their average age was 53.3 years. The most common indication for DBS revision was suboptimal clinical outcome, leading to 25/45 (55.6%) revision surgeries in our series. Infection occurred in a total of 15/45 (33.3%) cases. The average times to removal and subsequent reimplantation were 17.8 and 5.3 months, respectively. Lead fracture resulted in 5/45 (11.1%) cases of reoperation. The original DBS targets were reused in 39/45 (86.7%) of revision surgeries.

    Conclusions: DBS has improved the quality of life in many patients with irreversible, chronic conditions. Patients are informed of the risk of initial surgery and generator maintenance, but the risk for intracranial lead revision has not been clearly defined. DBS surgery is associated with a 6.9% rate of reoperation.

    Patient Care: Our research provides information about the risk associated with having or maintaining a complex implanted device. Patients should be fully educated about the potential risks they face with having DBS surgery.

    Learning Objectives: By the conclusion of this session, participants should be able to 1) describe the most common indications for reoperation on intracranial DBS leads, 2) discuss common complications of DBS, 3) discuss the impact of undergoing multiple lead revisions in patients

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy